Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
492
datasets available to search
ShareScore release 0.9.0
Dataset results
492 results for “EGFR mutations;”
Furmonertinib in Patients With Leptomeningeal Metastases Associated With EGFR Mutated NSCLC
ClinicalTrials.gov study NCT05813522. IPD Sharing: NO. Countries: 1. Publications: 0.
Lazertinib+Pemetrexed/Carboplatin in Patients With EGFR Sensitizing Mutation Positive Recurrent or Metastatic Non-Small Cell Lung Cancer Failed to Prior Lazertinib
ClinicalTrials.gov study NCT05786430. IPD Sharing: NO. Countries: 1. Publications: 0.
An epidemiOlogy Study to deteRmine the Prevalence of EGFR (Epidermal Growth Factor Receptor) muTations in RUSsian Patients With Advanced NSCLC (Non-Small Cell Lung Cancer).
ClinicalTrials.gov study NCT02321046. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Zipalertinib in Patients With Advanced Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions or Other Uncommon Mutation.
ClinicalTrials.gov study NCT05967689. IPD Sharing: NO. Countries: 12. Publications: 0.
A Prospective Study of Pembrolizumab Combining Chemotherapy in Advanced NSCLC Patients With EGFR Exon 21 Point Mutation.
ClinicalTrials.gov study NCT06142617. IPD Sharing: NO. Countries: 1. Publications: 0.
Almonertinib for Advanced NSCLC Patients With Rare Mutations in EGFR
ClinicalTrials.gov study NCT04785742. IPD Sharing: NO. Countries: 1. Publications: 0.
Synergistic Effect of Elemene Plus TKIs Compared With TKIs in EGFR-mutated Advanced NSCLC：Retrospective Study
ClinicalTrials.gov study NCT04397432. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Iressa Re-challenge in Advanced NSCLC EGFR-mutated Patients
ClinicalTrials.gov study NCT02025218. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Detection of EGFR Mutations in the Blood of Patients With Non-small Cell Lung Cancer: a Feasibility Study
ClinicalTrials.gov study NCT00717002. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Gefitinib Combine Radiotherapy as Therapy for Patients With NSCLC Harbouring Sensitive Mutations of EGFR
ClinicalTrials.gov study NCT03381430. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Best EGFR-TKI Sequence in NSCLC Harboring EGFR Mutations
ClinicalTrials.gov study NCT04811001. IPD Sharing: Not stated. Countries: 1. Publications: 0.
JMT101 Combined With Osimertinib in Patients With Stage Ⅲb-Ⅳ Non-small Cell Lung Cancer (NSCLC) Characterized by Epithermal Growth Factor Receptor (EGFR) Common Mutations
ClinicalTrials.gov study NCT06391944. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of Osimertinib in Patients with a Lung Cancer with Brain or Leptomeningeal Metastases with EGFR Mutation
ClinicalTrials.gov study NCT04233021. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
EGF816 and Trametinib in Patients With Non-small Cell Lung Cancer Harboring Activating EGFR Mutations
ClinicalTrials.gov study NCT03516214. IPD Sharing: UNDECIDED. Countries: 2. Publications: 0.
Diagnosis and Treatment Strategies in Patients With NSCLC With or Without EGFR Mutations.
ClinicalTrials.gov study NCT01525199. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Non-interventional Study (NIS) Registry for the Epidemiological and Scientific Evaluation of Epidermal Growth Factor Receptor (EGFR) Mutation Status in Patients With Newly Diagnosed Locally Advanced
ClinicalTrials.gov study NCT01153399. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Gefitinib Combined With Chemotherapy or Antiangiogensis in Patients With Bim Deletion or Low EGFR Mutation Abundance
ClinicalTrials.gov study NCT02930954. IPD Sharing: YES. Countries: 1. Publications: 0.
Evaluation of the Response to Tyrosine Kinase Inhibitors in Localized Non-small Cell Lung Cancer (NSCLC) Patients With EGFR Mutation in a Patient-derived Organoid Model
ClinicalTrials.gov study NCT05136014. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Tailored Second Line Treatment by Epidermal Growth Factor Receptor (EGFR) Mutation in Patients With Advanced Lung Adenocarcinoma
ClinicalTrials.gov study NCT00903292. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Assessing an Oral EGFR Inhibitor, DZD9008 in Patients With Advanced Non-small Cell Lung Cancer(NSCLC) With EGFR Mutations (WU-KONG15)
ClinicalTrials.gov study NCT05559645. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.